How much can CRISPR really do? Has the FDA been totally honest? And is it OK to mix and match Covid-19 vaccines?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First we talk to George Yancopoulos, head scientist at Regeneron Pharmaceuticals, about the future of CRISPR genome editing and the latest idea for treating obesity. Then, we discuss STAT’s reporting on the cozy relationship between Biogen and the FDA ahead of Aduhelm’s approval and what the ensuing fallout might mean. Before all that, we chat about the latest news in biotech, including vaccine boosters and a decadelong debacle.
For more on what we cover, here’s the Intellia news; here’s the Biogen story; here’s the 2021 STAT Breakthrough Science Summit; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.
Be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
Create a display name to comment
This name will appear with your comment
